Literature DB >> 2548953

Comparative study on the antiviral activity of tumor necrosis factor (TNF)-alpha, lymphotoxin/TNF-beta, and IL-1 in WISH cells.

V Ruggiero1, G Antonelli, M Gentile, G Conciatori, F Dianzani.   

Abstract

We find that pretreatment of WISH cells with tumor necrosis factor (TNF)-alpha, IL-1, and lymphotoxin/TNF-beta is capable of inducing an antiviral state in these cells, thereby protecting them from vesicular stomatitis virus cytopathic effect. Furthermore, we find that such a treatment causes a major inhibition of the synthesis of VSV proteins, as analyzed by SDS-PAGE. The 2-5A synthetase activity is also increased by treating the cells with doses of cytokines effective in antiviral protection. In this cell system, inclusion of polyclonal antibodies to IFN-beta during cytokine pretreatment abrogates the antiviral state elicited by the above cytokines, while antibodies to IFN-beta 2/IL-6 fail to abolish the cytokine-induced antiviral effects.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548953     DOI: 10.1016/0165-2478(89)90054-0

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  3 in total

1.  Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus. A prospective, double-blind, randomized study.

Authors:  E Villa; P Trande; A Grottola; P Buttafoco; A M Rebecchi; T Stroffolini; F Callea; A Merighi; L Camellini; P Zoboli; R Cosenza; L Miglioli; P Loria; R Iori; N Carulli; F Manenti
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

2.  Interleukin-17A Promotes CD8+ T Cell Cytotoxicity To Facilitate West Nile Virus Clearance.

Authors:  Dhiraj Acharya; Penghua Wang; Amber M Paul; Jianfeng Dai; David Gate; Jordan E Lowery; Dobrivoje S Stokic; A Arturo Leis; Richard A Flavell; Terrence Town; Erol Fikrig; Fengwei Bai
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

3.  Inoculation of swine with foot-and-mouth disease SAP-mutant virus induces early protection against disease.

Authors:  Fayna Díaz-San Segundo; Marcelo Weiss; Eva Pérez-Martín; Camila C Dias; Marvin J Grubman; Teresa de los Santos
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.